Remove Competition Remove Medicine Remove Pharmaceutical research
article thumbnail

Navigating Pharma Sales Challenges: Tips to Boost Your Sales Performance (Use of AI and Social Media for Effective brand promotion)

Pharmaceutical Representative Training

The Evolution of Pharma Sales: Combining AI and Social Media to Promote Brands Pharmaceutical businesses now have access to a whole new level of insights due to social media. Social medias position in pharmaceutical research is further cemented by peoples growing usage of it.

Media 52
article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

There was an article that examine the market for generic medicines in the Malaysia, following the introduction of the first generic patent in 2010 and the introduction of generic patent law in 2012. The market for medicines in Malaysia is divided between private clinics, private clinics, and pharmacies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dawn of a new indication: how to study drugs for aging 

Pharmaceutical Technology

Dr. Nir Barzilai, the scientific director for TAME and the director of the Institute for Aging Research at the Albert Einstein College of Medicine, New York, says projects like the TAME trial could be what regulators need to see to prove the validity of clinical trials in this area.

FDA 145
article thumbnail

Primate models in pharma: What the future holds

Pharmaceutical Technology

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. While multiple testing labs that use non-human primates for research were contacted for this article, all declined to comment amidst the most recent news coverage.

Pharma 98
article thumbnail

Beating the Big C

Pharmaceutical Technology

” While Pfizer is currently testing 18 medicines targeted against pancreatic, breast and lung cancers, figures released by the Pharmaceutical Research and Manufacturers of America [PhRMA] in April 2008 reveal that research companies are currently testing a record-breaking 750 experimental cancer drugs in America alone. .”